John P. Bilello

4.7k total citations
36 papers, 1.1k citations indexed

About

John P. Bilello is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, John P. Bilello has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 16 papers in Epidemiology and 10 papers in Molecular Biology. Recurrent topics in John P. Bilello's work include SARS-CoV-2 and COVID-19 Research (12 papers), Viral Infections and Immunology Research (8 papers) and Viral gastroenteritis research and epidemiology (7 papers). John P. Bilello is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (12 papers), Viral Infections and Immunology Research (8 papers) and Viral gastroenteritis research and epidemiology (7 papers). John P. Bilello collaborates with scholars based in United States, Canada and Belgium. John P. Bilello's co-authors include Ronald C. Desrosiers, Alexandra Schäfer, Bryan R. Cullen, Xuezhong Cai, Rachel Hood Edwards, Nancy Raab‐Traub, Shihua Lu, Tomáš Cihlář, Harriet C. Isom and Jason K. Perry and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

John P. Bilello

34 papers receiving 1.1k citations

Peers

John P. Bilello
Hien Dang United States
Zhengming Gu United States
Rina Barouch‐Bentov United States
Richard R. Gontarek United States
Pauline Chugh United States
Samuel A. Williams United States
Hien Dang United States
John P. Bilello
Citations per year, relative to John P. Bilello John P. Bilello (= 1×) peers Hien Dang

Countries citing papers authored by John P. Bilello

Since Specialization
Citations

This map shows the geographic impact of John P. Bilello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Bilello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Bilello more than expected).

Fields of papers citing papers by John P. Bilello

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. Bilello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Bilello. The network helps show where John P. Bilello may publish in the future.

Co-authorship network of co-authors of John P. Bilello

This figure shows the co-authorship network connecting the top 25 collaborators of John P. Bilello. A scholar is included among the top collaborators of John P. Bilello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John P. Bilello. John P. Bilello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Dong, Pui Yan Ho, Jiani Li, et al.. (2025). Remdesivir and Obeldesivir Retain Potent Antiviral Activity Against SARS-CoV-2 Omicron Variants. Viruses. 17(2). 168–168. 1 indexed citations
2.
Citron, Michael, Meng Shi, William Rose, et al.. (2024). Evaluation of a non-nucleoside inhibitor of the RSV RNA-dependent RNA polymerase in translatable animals models. Journal of Infection. 89(6). 106325–106325. 1 indexed citations
3.
Khan, Mona, Birgit Weynand, Manon Laporte, et al.. (2024). A robust mouse model of HPIV-3 infection and efficacy of GS-441524 against virus-induced lung pathology. Nature Communications. 15(1). 7765–7765. 2 indexed citations
4.
Gordon, Calvin J., Simon Walker, Egor P. Tchesnokov, et al.. (2024). Mechanism and spectrum of inhibition of a 4′-cyano modified nucleotide analog against diverse RNA polymerases of prototypic respiratory RNA viruses. Journal of Biological Chemistry. 300(8). 107514–107514. 4 indexed citations
5.
Demarest, James F., Ruxandra Draghia‐Akli, Tomáš Cihlář, et al.. (2024). Antiviral target compound profile for pandemic preparedness. Nature Reviews Drug Discovery. 24(2). 151–152. 1 indexed citations
7.
Malone, Brandon, Jason K. Perry, Paul Dominic B. Olinares, et al.. (2023). Structural basis for substrate selection by the SARS-CoV-2 replicase. Nature. 614(7949). 781–787. 42 indexed citations
8.
Pitts, Jared, Jiani Li, Jason K. Perry, et al.. (2022). Remdesivir and GS-441524 Retain Antiviral Activity against Delta, Omicron, and Other Emergent SARS-CoV-2 Variants. Antimicrobial Agents and Chemotherapy. 66(6). e0022222–e0022222. 48 indexed citations
9.
Pitts, Jared, Darius Babusis, Meghan S. Vermillion, et al.. (2022). Intravenous delivery of GS-441524 is efficacious in the African green monkey model of SARS-CoV-2 infection. Antiviral Research. 203. 105329–105329. 5 indexed citations
10.
Xie, Xuping, Antonio E. Muruato, Xianwen Zhang, et al.. (2021). Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19. Nature Communications. 12(1). 3984–3984.
11.
Perry, Jason K., T.C. Appleby, John P. Bilello, et al.. (2021). An atomistic model of the coronavirus replication-transcription complex as a hexamer assembled around nsp15. Journal of Biological Chemistry. 297(4). 101218–101218. 29 indexed citations
12.
Gordon, Calvin J., Egor P. Tchesnokov, Jason K. Perry, et al.. (2021). Efficient incorporation and template-dependent polymerase inhibition are major determinants for the broad-spectrum antiviral activity of remdesivir. Journal of Biological Chemistry. 298(2). 101529–101529. 25 indexed citations
13.
Dan, Thuc Nguyen, Kim Donckers, Laura Vangeel, et al.. (2021). A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents. Antiviral Research. 192. 105122–105122. 39 indexed citations
14.
Xie, Xuping, Antonio E. Muruato, Xianwen Zhang, et al.. (2020). A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19. Nature Communications. 11(1). 142 indexed citations
15.
Dousson, Cyril B., Christopher Chapron, David N. Standring, et al.. (2011). 815 IDENIX NS5A HCV REPLICATION INHIBITORS WITH LOW PICOMOLAR, PAN-GENOTYPIC IN VITRO ANTIVIRAL ACTIVITY. Journal of Hepatology. 54. S326–S327. 7 indexed citations
16.
Bilello, John P., Massimiliano La Colla, Michel Liuzzi, et al.. (2009). 344 PRECLINICAL PROFILES OF IDX136 AND IDX316, TWO NOVEL MACROCYCLIC HCV PROTEASE INHIBITORS. Journal of Hepatology. 50. S132–S132. 1 indexed citations
17.
Schäfer, Alexandra, Xuezhong Cai, John P. Bilello, Ronald C. Desrosiers, & Bryan R. Cullen. (2007). Cloning and analysis of microRNAs encoded by the primate γ-herpesvirus rhesus monkey rhadinovirus. Virology. 364(1). 21–27. 47 indexed citations
18.
Cai, Xuezhong, Alexandra Schäfer, Shihua Lu, et al.. (2006). Epstein–Barr Virus MicroRNAs Are Evolutionarily Conserved and Differentially Expressed. PLoS Pathogens. 2(3). e23–e23. 437 indexed citations
19.
Isom, Harriet C., Ayman M. Abdelhamed, John P. Bilello, & Thomas G. Miller. (2004). Baculovirus-Mediated Gene Transfer for the Study of Hepatitis B Virus. Humana Press eBooks. 96. 219–238. 5 indexed citations
20.
Bilello, John P., Edward E. Cable, Roland L. Myers, & Harriet C. Isom. (2003). Role of paracellular junction complexes in baculovirus-mediated gene transfer to nondividing rat hepatocytes. Gene Therapy. 10(9). 733–749. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026